Home Excelencia Severo Ochoa
Selected papers
Sanz G, Fuster V, Guzmán L, Guglietta A, Arnáiz JA, Martínez F, Sarria A, Roncaglioni MC, Taubert K. The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives. Am Heart J (2011) 162:811-817.e1
Fuster V, Kelly BB, Vedanthan R. Promoting global cardiovascular health: moving forwardCirculation (2011) 123:1671-8
Soderquest K, Powell N, Luci C, van Rooijen N, Hidalgo A, Geissmann F, Walzer T, Lord GM, Martín-Fontecha A. Monocytes control natural killer cell differentiation to effector phenotypesBlood (2011) 117:4511-8
Garaulet M, Sánchez-Moreno C, Smith CE, Lee YC, Nicolás F, Ordovás JM. Ghrelin, Sleep Reduction and Evening Preference: Relationships to CLOCK 3111 T/C SNP and Weight Loss. Plos One (2011) 6:e17435
Fuster V, Sweeny JM. Aspirin: a historical and contemporary therapeutic overview. Circulation (2011) 123:768-78
Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, Blanco-Colio L, Lavin B, Mallavia B, Tarin C, Mas S, Ortiz A and Egido J. Animal models of cardiovascular diseasesJ Biomed Biotechnol (2011) 2011:497841
Franco M, Cooper RS, Bilal U, Fuster V. Challenges and opportunities for cardiovascular disease prevention. Am J Med (2011) 124:95-102
Ibanez B, Fuster V, Jiménez-Borreguero J, Badimon JJ. Lethal myocardial reperfusion injury: A necessary evil?Int J Cardiol (2011) 151:3-11
Mearns BM, Fuster V. Highlight dementia risk to reduce CVD. Nat Rev Cardiol (2010) 7:237
Sanz J, Fuster V. Update in Cardiology. Ann Intern Med (2010) 152:786-91
47 Record/s1,2,3,4,5[>/>>]

The ACI department is dedicated to developing noninvasive technologies for molecular-resolution imaging. Through these technologies, vulnerable plaques can be identified and characterized, providing invaluable information on the underlying molecular mechanisms of disease and leading to tools for accurate diagnosis and targeted drug delivery.